The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown

The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown

Introduction: Coronavirus disease 2019 (COVID-19) in patients with hip fractures is associated with increased incidence of venous thromboembolism (VTE). The purpose of this study was to evaluate the hemostatic alterations of COVID-19 that are associated with a higher thrombotic risk using rotational...

Full description

Bibliographic Details
Main Authors: Andreas G. Tsantes, Dimitrios V. Papadopoulos, Ioannis G. Trikoupis, Stavros Goumenos, Daniele Piovani, Konstantina A. Tsante, Andreas F. Mavrogenis, Aristeidis G. Vaiopoulos, Panagiotis Koulouvaris, Georgios K. Nikolopoulos, Panayiotis J. Papagelopoulos, Stefanos Bonovas, Argirios E. Tsantes
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
hip fractures
coagulopathy
thrombotic risk
fibrinolysis shutdown
Online Access:https://www.mdpi.com/2077-0383/10/15/3397

Internet

https://www.mdpi.com/2077-0383/10/15/3397

Similar Items